CVRdatabase
Menu

Zyneyro ApS

Private limited companyCVR 42057428København NActive

Zyneyro ApS is a private limited company, based in København N, active in manufacture of pharmaceutical preparations, founded in 2021. The company went from a profit in 2024 to a loss of DKK 7.5m in 2025. Equity grew to DKK 4.1m in 2025. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 4.6m−209.2% vs. 2024
Net profit−DKK 7.5m−1,221.2% vs. 2024
EquityDKK 4.1m+575.7% vs. 2024
Employees10latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 209% (2024 → 2025), to −DKK 4.6m.
  • Net profit went from a profit of DKK 666k to a loss of DKK 7.5m (2024 → 2025).
  • Equity rose 576% (2024 → 2025), to DKK 4.1m.

Employees

  • 1 more employees than a year earlier: 10 (07/2026) against 9 (07/2025).

Management and owners, last 24 months

  • New in management: Steen Søren Klysner (director, 01/11/2024) and Erik Vinther (board member, 01/07/2025).
  • Stepped down: Peter Horn Møller (director, 31/10/2024).
  • New owners registered: Marigold Innovation ApS (22/05/2026), Ifo ApS (22/05/2026) and UGether ApS (22/05/2026) (+8).
  • No longer registered as owner: Marigold Innovation ApS (23/03/2025), Ifo ApS (23/03/2025) and UGether ApS (23/03/2025) (+7).

Registrations, last 24 months

  • 15/09/2026: Share capital changed from 51,228 DKK to 52,632 DKK
  • 23/07/2026: Share capital changed from 50,526 DKK to 51,228 DKK
  • 22/05/2026: Share capital changed from 49,123 DKK to 50,526 DKK
  • 21/04/2026: Share capital changed from 48,421 DKK to 49,123 DKK
  • 02/03/2026: Share capital changed from 47,719 DKK to 48,421 DKK
  • 01/10/2025: Share capital changed from 44,912 DKK to 47,719 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2025 · amounts in DKK thousand

Equity and net profit

−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2mDKK 4m20212022202320242025
EquityNet profit
Financial figures for Zyneyro ApS
20212022202320242025Change
Revenuenot statednot statednot statednot statednot stated–
Gross profit−27−271,0304,169−4,551−209.2%
Operating profit (EBIT)−27−2758711−9,255−1,401.7%
Profit before tax−29−28−35709−9,273−1,407.1%
Net profit−29−28−35666−7,466−1,221.2%
Total assets4648575401,4175,269+271.9%
Equity11−18−526144,147+575.7%
Liabilities4538755928031,122+39.7%
Cash and cash equivalents263171561,3083,117+138.3%
Average number of employees00450−100%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2mDKK 4m20212022202320242025
Gross profitMedian, the industry (59 companies)

Annual reports

5 financial years
Annual reports for Zyneyro ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202520/04/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202416/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202317/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202220/06/2023The companyPDFXBRL
202126/01/2021 – 31/12/202115/06/2022The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101208/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profit−DKK 4.6mNo. 45 of 57
Better than 21% of the companies in the industry
EquityDKK 4.1mNo. 34 of 59
Better than 43% of the companies in the industry
Number of employees10No. 52 of 59
Better than 12% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bn
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,506of 69,742
Better than 0%
No. 15,965of 69,964
Better than 77%
Same industry and fewer than 20 employees37 companies in the comparison
No. 27of 36
Better than 26%
No. 16of 37
Better than 58%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,424of 33,588
Better than 0%
No. 6,906of 33,687
Better than 80%
All companies of type ApS66,508 companies in the comparison
No. 66,177of 66,379
Better than 0%
No. 12,805of 66,505
Better than 81%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. Zyneyro ApS−DKK 4.6m
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. Zyneyro ApS−DKK 7.5m
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. Zyneyro ApSDKK 4.1m
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. Zyneyro ApS10
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Zyneyro ApS

Management

6 active registrations

Executive management

Executive management at Zyneyro ApS
NameRoleAppointed
Steen Søren KlysnerDirector01/11/2024

Board of directors

Board of directors at Zyneyro ApS
NameRoleAppointed
Jacob ØrndrupChair of the board26/01/2021
Andreas Toft SørensenBoard member26/01/2021
Ulrik GetherBoard member15/02/2021
Kenneth Lindegaard MadsenBoard member15/02/2021
Erik VintherBoard member01/07/2025
Founders
Marigold Innovation ApS, Ifo ApS, UGether ApS, KLMBio ApS
Former management (2)
Former management at Zyneyro ApS
NameRoleAppointedResigned
Peter Horn MøllerDirector26/01/202131/10/2024
Peter Horn MøllerBoard member26/01/202115/02/2021

Signing rule: Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af formanden for bestyrelsen i forening med en direktør.

Address and production units

2 active production units

Ole Maaløes Vej 3
2200 København N

København Municipality · Postcode 2200

Other companies at the address (8)

  • BII Holdings A/SOther financial service activities n.e.c.
  • Skape Bio ApSResearch and experimental development on natural sciences and engineering
  • Agrobiomics ApSResearch and experimental development on natural sciences and engineering
  • Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
  • BioColor ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
Zyneyro ApSOle Maaløes Vej 3, 2200 København N101026724844
Zyneyro ApSBlegdamsvej 3B, 5, 2200 København N–1032864585

Purpose

Selskabets formål er forskning og udvikling af lægemidler, samt dermed beslægtet virksomhed

The purpose is quoted from the register in Danish.

Changes year by year

61 registered events
202616 changescapital 5 · ownership 10 · accounts 1
  • Share capital changed from 51,228 DKK to 52,632 DKK
  • Share capital changed from 50,526 DKK to 51,228 DKK
  • Share capital changed from 49,123 DKK to 50,526 DKK
  • Marigold Maturation Fund K/S registered as owner (20%)
  • KLMBio ApS registered as owner (15%)
  • UGether ApS registered as owner (15%)
  • IFO ApS registered as owner (15%)
  • Marigold Innovation ApS registered as owner (15%)
  • Marigold Maturation Fund K/S is no longer registered as owner
  • IFO ApS is no longer registered as owner
  • Marigold Innovation ApS is no longer registered as owner
  • UGether ApS is no longer registered as owner
  • KLMBio ApS is no longer registered as owner
  • Share capital changed from 48,421 DKK to 49,123 DKK
  • Annual report for 2025 published
  • Share capital changed from 47,719 DKK to 48,421 DKK
202518 changescapital 3 · ownership 11 · management 1 · accounts 1 · address 2
  • Share capital changed from 44,912 DKK to 47,719 DKK
  • Marigold Maturation Fund K/S registered as owner (15%)
  • Marigold Maturation Fund K/S is no longer registered as owner
  • Share capital changed from 42,456 DKK to 44,912 DKK
  • Erik Vinther appointed board member
  • Annual report for 2024 published
  • Moved to Ole Maaløes Vej 3, 2200 København N
  • Moved to Ole Maaløes Vej 3, 2200 København N
  • Share capital changed from 40,000 DKK to 42,456 DKK
  • IFO ApS registered as owner (20%)
  • Marigold Innovation ApS registered as owner (20%)
  • UGether ApS registered as owner (20%)
  • KLMBio ApS registered as owner (20%)
  • Marigold Maturation Fund K/S registered as owner (5%)
  • KLMBio ApS is no longer registered as owner
  • Marigold Innovation ApS is no longer registered as owner
  • UGether ApS is no longer registered as owner
  • IFO ApS is no longer registered as owner
20243 changesmanagement 2 · accounts 1
  • Steen Søren Klysner appointed director
  • Peter Horn Møller stepped down as director
  • Annual report for 2023 published
20232 changesaccounts 1 · name 1
  • Annual report for 2022 published
  • Name changed from DolorestBio ApS to Zyneyro ApS
202210 changesownership 8 · accounts 1 · address 1
  • KLMBio ApS registered as owner (25%)
  • Marigold Innovation ApS registered as owner (25%)
  • UGether ApS registered as owner (25%)
  • IFO ApS registered as owner (25%)
  • KLMBio ApS is no longer registered as owner
  • IFO ApS is no longer registered as owner
  • Marigold Innovation ApS is no longer registered as owner
  • UGether ApS is no longer registered as owner
  • Annual report for 2021 published
  • Moved to Agern Alle 24, 2970 Hørsholm
202112 changesmanagement 7 · founded 1 · ownership 4
  • Ulrik Gether appointed board member
  • Kenneth Lindegaard Madsen appointed board member
  • Peter Horn Møller stepped down as board member
  • Registered as DolorestBio ApS
  • Peter Horn Møller appointed director
  • Peter Horn Møller appointed board member
  • Jacob Ørndrup appointed chair of the board
  • Andreas Toft Sørensen appointed board member
  • KLMBio ApS registered as owner (25%)
  • IFO ApS registered as owner (25%)
  • Marigold Innovation ApS registered as owner (15%)
  • UGether ApS registered as owner (25%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction